international medications

The U.S. Customs and Border Protection Agency generally prohibits the importation of more than a 90-day supply of medication. This policy aims to balance the need for drug safety with recognizing that many Americans turn to international sources for their prescription medications due to high domestic prices or availability issues. Despite strict regulations, the FDA inspects less than 1% of all packages presumed to contain drugs, significantly reducing the likelihood of small personal shipments being intercepted. This article explores the complexities and implications of current import regulations and highlights the efforts of organizations like Ashvin Medicara to advocate for better access to affordable medications.